GO
Loading...

Altana Says Full-year Sales Rose 18% on Foreign Demand

German chemicals maker Altana said Friday that full-year sales rose 18% as the company benefited from rising foreign demand.

Revenue for the year through Dec. 31 rose to 3.9 billion euros ($5.06 billion) from 3.3 billion euros in the same period a year earlier, the company said in a statement.

"This growth was mainly driven by foreign business," the company said in a statement.

Altana expects its chemicals business to post an operating sales growth of less that 10% in fiscal 2007. The medium-range growth target is set at average sales growth of 10%

Regulators last month cleared Altana to sell its drugs unit to Denmark's Nycomed Holding for 4.5 billion euros ($5.71 billion). The European Commission said the deal would not cause any antitrust problems in Europe as there was only a limited overlap between the two companies.

Altana's shares fell 0.4% to 47.09 euros ($61.11) on the Deutsche Boerse.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Discussing if stocks are overvalued and if earnings will continue to climb, with Oliver Pursche, Gary Goldberg Financial Services, and Adam Thurgood, HighTower.

  • Some MBAs are passing up internships on Wall Street to work on Main Street. MBAs Across America Founder and CEO Casey Gerald and Red Ants Pants Owner Sarah Calhoun reveal how they're convincing America's top business minds to help small business owners in a town near you.

  • The Knee Defender is a controversial device that has air travelers arguing over reclining seats. Its creator Ira Goldman explains why it's the airlines, not his device, that's to blame and how his business is flying high off of the publicity.